HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) shares passed below its 50-day moving average during trading on Wednesday. The stock has a 50-day moving average of $97.70 and traded as low as $91.00. HealthEquity shares last traded at $91.90, with a volume of 893,026 shares traded.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on HQY shares. Telsey Advisory Group set a $111.00 price target on HealthEquity in a research note on Friday, August 28th. Citigroup restated a “market outperform” rating on shares of HealthEquity in a report on Friday, August 28th. Wall Street Zen lowered shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. Weiss Ratings cut shares of HealthEquity from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 2nd. Finally, BTIG Research restated a “buy” rating and issued a $115.00 price objective on shares of HealthEquity in a research report on Friday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, HealthEquity has an average rating of “Moderate Buy” and a consensus target price of $112.20.
Get Our Latest Stock Report on HealthEquity
HealthEquity Stock Performance
HealthEquity (NASDAQ:HQY – Get Free Report) last issued its quarterly earnings data on Thursday, August 27th. The company reported $1.24 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.05. HealthEquity had a net margin of 17.36% and a return on equity of 15.33%. The company had revenue of $350.73 million during the quarter, compared to the consensus estimate of $349.22 million. The company’s quarterly revenue was up 95.5% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 4.660-4.730 EPS. As a group, research analysts forecast that HealthEquity, Inc. will post 3.93 EPS for the current year.
Insiders Place Their Bets
In other news, Director Adrian Dillon sold 7,632 shares of the firm’s stock in a transaction that occurred on Tuesday, August 25th. The shares were sold at an average price of $104.61, for a total transaction of $798,383.52. Following the completion of the transaction, the director directly owned 62,395 shares of the company’s stock, valued at $6,527,140.95. This trade represents a 10.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.60% of the stock is currently owned by company insiders.
Institutional Trading of HealthEquity
A number of institutional investors have recently made changes to their positions in the business. Fifth Third Wealth Advisors LLC increased its stake in shares of HealthEquity by 4.2% in the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after purchasing an additional 116 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of HealthEquity by 12.0% during the 3rd quarter. GAMMA Investing LLC now owns 1,479 shares of the company’s stock worth $131,000 after buying an additional 158 shares during the last quarter. Cim Investment Management Inc. lifted its position in shares of HealthEquity by 5.0% during the 2nd quarter. Cim Investment Management Inc. now owns 4,007 shares of the company’s stock worth $362,000 after buying an additional 191 shares during the last quarter. State of Michigan Retirement System boosted its stake in HealthEquity by 1.0% in the first quarter. State of Michigan Retirement System now owns 20,522 shares of the company’s stock valued at $1,715,000 after buying an additional 200 shares in the last quarter. Finally, Leonteq Securities AG grew its position in HealthEquity by 159.9% in the first quarter. Leonteq Securities AG now owns 382 shares of the company’s stock valued at $32,000 after acquiring an additional 235 shares during the last quarter. Institutional investors own 99.55% of the company’s stock.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) provides technology-enabled services for consumer-directed health and benefits accounts. The company administers health savings accounts (HSAs) and offers related products such as flexible spending accounts, health reimbursement arrangements, commuter benefits and other employee benefit programs.
Its platform is designed to help employers, benefits advisors, health plans and individuals manage benefits, make healthcare payments, access account information and invest eligible HSA funds.
Further Reading
- Five stocks we like better than HealthEquity
- Alphabet Introduces Gemini Agent—Can It Trigger a Breakout?
- Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November Earnings
- Tilray Finds a Path to Growth Without Waiting on U.S. Cannabis Reform
- Arista Networks Plugs Into All-Time Highs
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
